{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T04:22:15Z","timestamp":1686630135804},"reference-count":27,"publisher":"Society of Nuclear Medicine","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Nucl. Med. Technol."],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.2967\/jnmt.123.265635","type":"journal-article","created":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T14:10:34Z","timestamp":1685715034000},"page":"129-132","source":"Crossref","is-referenced-by-count":0,"title":["The Rise of Cardiac Amyloidosis Imaging"],"prefix":"10.2967","volume":"51","author":[{"given":"Bharadwaj","family":"Satyavolu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Deitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prem","family":"Soman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1602","published-online":{"date-parts":[[2023,6,2]]},"reference":[{"key":"2023061207251321000_51.2.129.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2005.10.005"},{"key":"2023061207251321000_51.2.129.2","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2022.11.022","article-title":"2023 ACC expert consensus decision pathway on comprehensive multidisciplinary care for the patient with cardiac amyloidosis","volume":"81","author":"Kittleson","year":"2023","journal-title":"J Am Coll Cardiol."},{"key":"2023061207251321000_51.2.129.3","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2016-310704"},{"key":"2023061207251321000_51.2.129.4","doi-asserted-by":"crossref","unstructured":"Ruberg FL Berk JL . Contemporary reviews in cardiovascular medicine: transthyretin (TTR) cardiac amyloidosis. 2012;126:1286\u20131300.","DOI":"10.1161\/CIRCULATIONAHA.111.078915"},{"key":"2023061207251321000_51.2.129.5","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehs123"},{"key":"2023061207251321000_51.2.129.6","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2013.094482"},{"key":"2023061207251321000_51.2.129.7","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.jaccao.2021.06.006","article-title":"ATTR amyloidosis: current and emerging management strategies: JACC: CardioOncology state-of-the-art review","volume":"3","author":"Griffin","year":"2021","journal-title":"JACC CardioOncol."},{"key":"2023061207251321000_51.2.129.8","doi-asserted-by":"publisher","DOI":"10.1161\/cir.0000000000000792"},{"key":"2023061207251321000_51.2.129.9","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s10741-021-10080-2","article-title":"Screening for ATTR amyloidosis in the clinic: overlapping disorders, misdiagnosis, and multiorgan awareness","volume":"27","author":"Nativi-Nicolau","year":"2022","journal-title":"Heart Fail Rev."},{"key":"2023061207251321000_51.2.129.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2020.08.027"},{"key":"2023061207251321000_51.2.129.11","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1007\/s12350-022-03059-5","article-title":"Radiopharmaceutical supply disruptions and the use of 99mTc-hydroxymethylene diphosphonate as an alternative to 99mTc-pyrophosphate for the diagnosis of transthyretin cardiac amyloidosis: an ASNC information statement","volume":"29","author":"Miller","year":"2022","journal-title":"J Nucl Cardiol."},{"key":"2023061207251321000_51.2.129.12","doi-asserted-by":"crossref","first-page":"4524","DOI":"10.1093\/eurheartj\/ehaa653","article-title":"Hearts and bones: choose your tracers wisely","volume":"41","author":"Chandrashekar","year":"2020","journal-title":"Eur Heart J."},{"key":"2023061207251321000_51.2.129.13","doi-asserted-by":"publisher","DOI":"10.1097\/00003072-197906000-00008"},{"key":"2023061207251321000_51.2.129.14","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(82)90343-X"},{"key":"2023061207251321000_51.2.129.15","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(83)80140-4"},{"key":"2023061207251321000_51.2.129.16","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.021612"},{"key":"2023061207251321000_51.2.129.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.05.073"},{"key":"2023061207251321000_51.2.129.18","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.112.000132"},{"key":"2023061207251321000_51.2.129.19","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s12350-019-01753-5","article-title":"Simultaneous Tc-99m PYP\/Tl-201 dual-isotope SPECT myocardial imaging in patients with suspected cardiac amyloidosis","volume":"27","author":"Tamarappoo","year":"2020","journal-title":"J Nucl Cardiol."},{"key":"2023061207251321000_51.2.129.20","unstructured":"American Society of Nuclear Cardiology. ASNC Cardiac amyloidosis practice points: 99mtechnetium-pyrophosphate imaging for transthyretin cardiac amyloidosis. https:\/\/www.asnc.org\/Files\/Practice%20Resources\/Practice%20Points\/ASNC%20Practice%20Point-99mTechnetiumPyrophosphateImaging2016.pdf. Updated February 2019. Accessed May 22, 2023."},{"key":"2023061207251321000_51.2.129.21","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.024438"},{"key":"2023061207251321000_51.2.129.22","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2012-302353"},{"key":"2023061207251321000_51.2.129.23","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.echo.2020.03.012","article-title":"Reduced diagnostic accuracy of apical-sparing strain abnormality for cardiac amyloidosis in patients with chronic kidney disease","volume":"33","author":"Singh","year":"2020","journal-title":"J Am Soc Echocardiogr."},{"key":"2023061207251321000_51.2.129.24","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000152819.97857.9D"},{"key":"2023061207251321000_51.2.129.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2012.11.013"},{"key":"2023061207251321000_51.2.129.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2020.04.007"},{"key":"2023061207251321000_51.2.129.27","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/eurheartj\/ehab072","article-title":"Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases","volume":"42","author":"Garcia-Pavia","year":"2021","journal-title":"Eur Heart J."}],"container-title":["Journal of Nuclear Medicine Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnmt.123.265635","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T14:27:27Z","timestamp":1686580047000},"score":1,"resource":{"primary":{"URL":"http:\/\/tech.snmjournals.org\/lookup\/doi\/10.2967\/jnmt.123.265635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":27,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,6,2]]},"published-print":{"date-parts":[[2023,6]]}},"alternative-id":["10.2967\/jnmt.123.265635"],"URL":"https:\/\/doi.org\/10.2967\/jnmt.123.265635","relation":{},"ISSN":["0091-4916","1535-5675"],"issn-type":[{"value":"0091-4916","type":"print"},{"value":"1535-5675","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6]]}}}